TGThe Guardian·1hBusiness
score+0.30
Kalshi to offer betting on drug trial results and FDA regulatory decisions
Original
Kalshi to offer betting on drug trial results and FDA regulatory decisions
“Factual reporting on business expansion with mixed undertones; neutral framing emphasizes innovation but omits potential ethical concerns about commodifying health outcomes.”